Micap Plc (LSE:MIC) is a bio-science company developing patented micro-encapsulation technology that uses single cell organisms such as yeast to create natural preformed micro-capsules for the industries such as food, pharmaceuticals and agro-chemicals.
Following the successful flotation on AIM on 7/8/03, Micap has a broad base of institutional and private investors, the largest investor being SkyePharma Plc, closely followed by Sigma Venture Funds.
In this interview, AZoNano visits the Graphene Engineering and Innovation Centre to talk with Mark Dickie, Composite Applications Manager, about how the GEIC is helping to take graphene composite innovation out of the lab and into the wider industry.
In this interview, we speak with Stanford's Gu Group about their newly developed metal nanocluster-based material that's advancing nanoscale 3D printing.
Professor Andre Nel
In this interview, AZoNano speaks with Professor Andre Nel about his involvement in innovative research describing the development of a 'glass bubble' nanocarrier that could help drug formulations access pancreatic cancer cells.
The MiniCapt® Pro is a remote microbial air sampler that is ideal for the pharmaceutical manufacturing industry.
This product profile outlines the NanoRacer High-Speed AFM from Bruker JPK.
NMR spectroscopy is a characterization technique that is extensively used by chemical researchers.